Roanoke Times Copyright (c) 1995, Landmark Communications, Inc. DATE: FRIDAY, May 4, 1990 TAG: 9005040445 SECTION: NATIONAL/INTERNATIONAL PAGE: A4 EDITION: METRO SOURCE: DATELINE: WASHINGTON LENGTH: Short
The drug was approved for use for patients 3 months to 12 years old who have fully developed AIDS or who are infected with the AIDS virus and show signs of a damaged immune system as measured through laboratory tests. In the latter group, they need not have overt symptoms of the disease. The drug already has been approved for adolescents and adults. - Los Angeles Times
by CNB